Deutsch J, Fritsch G, Gölles J, Semmelrock H J
J Pediatr Gastroenterol Nutr. 1986 Jul-Aug;5(4):542-8. doi: 10.1097/00005176-198607000-00006.
A cross-sectional study was performed to define patients at risk of developing liver disease due to long-term treatment with anticonvulsive drugs. The activities of gamma-glutamyltransferase, aspartate aminotransferase, and alanine aminotransferase and the concentrations of primidone, phenobarbital, phenytoin, and valproic acid in serum were estimated. Epileptic children before therapy were used as controls. The results indicated enzyme induction due to phenobarbital and both enzyme induction and liver cell damage or plasma membrane leakage due to phenytoin. Gamma-glutamyltransferase may be an early indicator of liver disease due to valproic acid.
进行了一项横断面研究,以确定因长期使用抗惊厥药物治疗而有患肝病风险的患者。评估了血清中γ-谷氨酰转移酶、天冬氨酸氨基转移酶和丙氨酸氨基转移酶的活性以及扑米酮、苯巴比妥、苯妥英和丙戊酸的浓度。治疗前的癫痫儿童用作对照。结果表明,苯巴比妥可导致酶诱导,苯妥英可导致酶诱导以及肝细胞损伤或质膜渗漏。γ-谷氨酰转移酶可能是丙戊酸所致肝病的早期指标。